• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

Icrucumab Antibody – Human Monoclonal

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5818791

Icrucumab (IMC-18F1) is a humanized IgG1 monoclonal antibody targeting vascular endothelial growth factor receptor-1. Icrucumab has antitumor activity. Icrucumab has been studied in metastatic colon cancer. More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
Icrucumab, Monoclonal Antibody
Full Product Name
Icrucumab
Product Synonym Names
LY 3012212; IMC-18F1
Clonality
Monoclonal
Host
Human
Species Reactivity
Vascular endothelial growth factor receptor-1
Preparation and Storage
Powder: -20 degree C for 3 years | In solvent: -80 degree C for 1 year
Solubility
(< 1 mg/ml refers to the product slightly soluble or insoluble)
CAS Number
1024603-92-6

Other Notes

Small volumes of anti-Icrucumab antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for Icrucumab purchase

MBS5818791 is an antibody targeting Icrucumab. Reactive in Vascular endothelial growth factor receptor-1. Host: Human.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000